Yan He

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Top Venues

Disease markers

Immunity, inflammation and disease

Clinical science (London, England : 1979)

Journal of interventional cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuming Liang, Yun Zhou, Jialin Wang, Yan He
Downregulation of fibromodulin attenuates inflammatory signaling and atrial fibrosis in spontaneously hypertensive rats with atrial fibrillation via inhibiting TLR4/NLRP3 signaling pathway. Immunity, inflammation and disease 11 (10) (2023)
Chenliang Ge, Yaxin Zhao, Yuming Liang, Yan He
Silencing of TLR4 Inhibits Atrial Fibrosis and Susceptibility to Atrial Fibrillation via Downregulation of NLRP3-TGF- β in Spontaneously Hypertensive Rats. Disease markers 2022 (2022)
Chenliang Ge, Yang Cheng, Yihao Fan, Yan He
Vincristine attenuates cardiac fibrosis through the inhibition of NLRP3 inflammasome activation. Clinical science (London, England : 1979) 135 (11) (2021)
Xing Liu, Chun Gui, Weiming Wen, Yan He, Weiran Dai, Guoqiang Zhong
Safety and Efficacy of High Power Shorter Duration Ablation Guided by Ablation Index or Lesion Size Index in Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis. Journal of interventional cardiology 2021 (2021)
Zhongyuan Meng, Yaxin Zhao, Yan He
Fibrinogen Level Predicts Outcomes in Critically Ill Patients with Acute Exacerbation of Chronic Heart Failure. Disease markers 2021 (2021)
Yuming Liang, Boqun Wang, Huijuan Huang, Maoyun Wang, Qianwen Wu, Yaxin Zhao, Yan He
Silenced SOX2-OT alleviates ventricular arrhythmia associated with heart failure by inhibiting NLRP3 expression via regulating miR-2355-3p. Immunity, inflammation and disease 9 (1) (2020)
Chenliang Ge, Yan He
A Novel Gene Signature to Predict Survival Time and Incident Ventricular Arrhythmias in Patients with Dilated Cardiomyopathy. Disease markers 2020 (2020)